1-Ethyl-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 500mg

2-(2-fluorophenyl)-2-(4-methyl-1H-pyrazol-1-yl)ethanamine hydrochloride (1:1), 1g

2,5-Dimethylfuran-3(2H)-one, 97.0%, 25g

6-METHOXY-2H-CHROMENE-3-CARBONITRILE, 95.0%, 5g

2-(6-Bromo-5-fluoropyridin-3-yl)acetic acid, 98%, 50mg

tert-Butyl 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]piperidine-1-carboxylate>98.0%(HPLC)(T)5g

Setaccio molecolare 5Å, 0,5 nm, tipo 522, a forma di perla, 250 g, confezione in vetro

1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid methyl ester, 95.0%, 25g

2-Methylbutylamine, 85.0%, 25ml

2-{[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino]methyl}propanedinitrile, 90%, 1g

5-Bromo-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 25g

METHYL 6-BROMO-4-CHLORONICOTINATE, 95.0%, 1g

3,4-DICHLORO-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE, 95.0%, 5g